Grail, the US-based oncology diagnostics startup spun out of biotech company Illumina, has received an undisclosed amount of funding from GV, the corporate venturing unit of internet technology conglomerate Alphabet, and appointed Jeff Huber, a former executive of Alphabet subsidiary Google, as its CEO. Illumina, Arch Venture Partners, Bezos Expeditions and Sutter Hill Ventures provided $100m in series A funding for Grail at the time of its launch last month.
Aasaanjobs, an India-based online recruitment marketplace backed by IT…
